Currently Viewing:
Newsroom
Currently Reading
What We're Reading: Alabama Abortion Protests; House Equality Act; Rising Suicide Rates Among Girls
May 20, 2019 – AJMC Staff
Concurrent Decline in FVC, Walking Test More Likely Associated With Disease Progression in IPF
May 18, 2019 – Samantha DiGrande
Providing Pain Relief for Patients With Bone Metastases
May 18, 2019 – Laura Joszt
Opicapone Can Increase Length of ON-Periods in Patients With Parkinson Disease
May 18, 2019 – Wallace Stephens
Dysregulated Energy Production in Stem Cells Implicated in Fanconi Anemia
May 18, 2019 – Allison Inserro
Study Examines Effects of Alcohol, HIV, HCV on Immune System Activation
May 18, 2019 – Wallace Stephens
First-in-Human Study of Dual Inhibitor Licogliflozin Showed Significant Weight Loss in Obese Patients
May 17, 2019 – Mary Caffrey
Researchers Identify Potential Cause of Relapses in MS
May 17, 2019 – Samantha DiGrande
Researchers Examine Metabolic Effects of Ruxolitinib
May 17, 2019 – Allison Inserro

AJMC® in the Press, February 15, 2019

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A study published in The American Journal of Managed Care® (AJMC®) was cited by RevCycle Intelligence. The researchers of the study, “Patients’ Views on Price Shopping and Price Transparency,” interviewed patients with access to a price transparency website and found that despite having a positive opinion of price shopping in theory, patients reported barriers to doing so in reality.

The National Pharmaceutical Council’s Wednesday CER Daily Newsfeed included 2 articles from AJMC® on curative therapies from the “Paying for Cures: Ensuring patient access and system sustainability” event. The article “Preparing Patients and the Health System for Curative Therapies in the Pipeline” covered a session where experts discussed how the healthcare system can pay for curative therapies that have high upfront costs with benefits that accrue over time. The article “Examining New Payment Ideas for Curative Therapies” sought to answer the question of how the health system can ensure that cutting-edge gene therapies and other curative therapies get to the patients that need them without leaving payers financially exposed.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up